Novanta Inc. (NOVT)
| Market Cap | 4.65B |
| Revenue (ttm) | 602.83M |
| Net Income (ttm) | 41.08M |
| Shares Out | 35.14M |
| EPS (ttm) | 1.15 |
| PE Ratio | 115.07 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 26 |
| Last Price | $132.33 |
| Previous Close | $133.83 |
| Change ($) | -1.50 |
| Change (%) | -1.12% |
| Day's Open | 134.38 |
| Day's Range | 131.99 - 136.78 |
| Day's Volume | 120,529 |
| 52-Week Range | 66.44 - 146.16 |
Novanta (NASDAQ:NOVT) releases its next round of earnings this Monday, March 01. Here is Benzinga's essential guide to Novanta's Q4 earnings report.
Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth q...
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matth...
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robe...
Novanta, Inc. (NOVT) CEO Matthijs Glastra on Q3 2020 Results - Earnings Call Transcript
Novanta (NOVT) delivered earnings and revenue surprises of 5.00% and 0.69%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Novanta (NASDAQ:NOVT) rose 0.8% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 20.75% over the past year to $0.42, which ...
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial ...
Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matt...
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third qu...
Top Ranked Momentum Stocks to Buy for August 28th
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc.
Novanta, Inc. (NOVT) CEO Matthijs Glastra on Q2 2020 Results - Earnings Call Transcript
Novanta (NOVT) delivered earnings and revenue surprises of 100.00% and 4.78%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc.
Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second q...
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (NASDAQ: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matt...
Novanta, Inc. (NOVT) CEO Matthijs Glastra on Q1 2020 Results - Earnings Call Transcript
Novanta (NOVT) delivered earnings and revenue surprises of 59.38% and 9.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Novanta (NASDAQ:NOVT) were unchanged at $87.91 after the company reported Q1 results.
Figuring out toxic stocks and abandoning them at the right time is the key to shield your portfolio from big losses.
Novanta Inc. (NOVT) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Novanta Inc. (NOVT) CEO Matthijs Glastra on Q4 2019 Results - Earnings Call Transcript
Novanta (NOVT) delivered earnings and revenue surprises of 1.85% and 1.61%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Novanta, Inc.: A Better Odds-On Capital-Gain Alternative To Intuitive Surgical
Here's your proof for taking a long-term approach to investing.
Novanta Inc. Buy-Ranked For Near Cap-Gains By Market-Makers
One familiar name tops the list, but the others may surprise you.
Novanta, Inc. (NOVT) CEO Matthijs Glastra on Q3 2019 Results - Earnings Call Transcript
Novanta (NOVT) delivered earnings and revenue surprises of 1.92% and -0.70%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Novanta (NOVT) delivered earnings and revenue surprises of 0.00% and 0.37%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CFO of Novanta Inc (NASDAQ:NOVT) Robert Buckley sold 16,277 shares of NOVT on 07/08/2019 at an average price of $91.06 a share.
Does Novanta (NOVT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Bright Near-Term Outlook for Electronics Components Industry
Novanta, Inc. (NOVT) CEO Matthijs Glastra on Q1 2019 Results - Earnings Call Transcript
Novanta (NOVT) possesses solid growth attributes, which could help it handily outperform the market.
Novanta (NOVT) delivered earnings and revenue surprises of 8.16% and 0.58%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Does Novanta (NOVT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Novanta is well positioned to outperform the market, as it exhibits above-average growth in financials.
About NOVT
Novanta, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. Its Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products for photonics-based applications, such as industrial processing, metrology, medical and life science imaging, DNA sequencing, an... [Read more...]
| Industry Scientific & Technical Instruments | Founded 1968 |
| CEO Matthijs Glastra | Employees 2,290 |
| Stock Exchange NASDAQ | Ticker Symbol NOVT |
Financial Performance
In 2019, Novanta's revenue was $626.10 million, an increase of 1.91% compared to the previous year's $614.34 million. Earnings were $40.77 million, a decrease of -16.97%.
Analyst Forecasts
According to 4 analysts, the average rating for Novanta stock is "Hold." The 12-month stock price forecast is 118.00, which is a decrease of -10.83% from the latest price.